What are my alternatives to knee replacement?
Compare nonsurgical knee arthritis care, injection choices, and selected surgical alternatives—with evidence, limits, and questions for your clinician.
Read the guide ↗Medically reviewed by Charles A. DeCook, MD ·
← All optionsSpecialist review
Genicular nerve RFA / block
Turn pain signals down. The joint stays the same.
Who might it suit?
For: Selected knee pain after pain-specialist assessment.
Not for: A permanent fix or a way to repair cartilage. Hip use needs review.
Limits and important cautions
A 2025 sham-focused review was less favorable than a broader 2026 review. Technique, comparators, and study quality differ; neither procedure repairs the joint.
What happens, how long, and what could it cost?
- What happens
- A specialist assesses the pain source; a nerve block and RFA are distinct procedures.
- When might I notice a change?
- A reliable personal timeline cannot be predicted from the evidence reviewed here. Agree on a review date before starting.
- How long might benefit last?
- Relief may be temporary; durability varies across techniques and studies.
- Repeat treatment
- Discuss the response to any block, the expected benefit of RFA, and criteria for repeating it.
- Activity and recovery
- Ask who provides follow-up, what symptoms need urgent attention, and what restrictions apply to you.
- Ask for a complete estimate
- Consultation, diagnostic block if used, ablation, facility fees, and follow-up.
Use this as a consultation guide. A timeline is not a guarantee; the evidence and FDA sections below remain part of the decision.
THE EVIDENCE IN CONTEXT
Short-term benefit possible; longer-term confidence varies
Read the 3 selected references
- Genicular nerve interventions: randomized-trial synthesis ↗
Sham comparisons suggested modest short-term RFA benefit, with low-to-very-low certainty and no sustained benefit at later measured time points.
- Kanjanapanang et al.: genicular RFA outcomes ↗
Includes randomized and observational studies; more favorable results for larger-lesion techniques. Pooled response rates are not placebo-adjusted treatment effects.
- ACR/Arthritis Foundation: OA management ↗
2019 guideline, published in 2020. Recommendations vary by joint; it predates many newer trials.
FDA status
Device clearance · selected knee painCOOLIEF has FDA 510(k) clearance for genicular nerve lesions in selected patients with chronic knee pain, including labeled selection criteria. This is device clearance, not blanket approval of every ablation or nerve-block technique. Local anesthetics used for blocks have their own labeling.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.What do professional guidelines say?
AAOS: Limited recommendation: denervation may reduce knee pain and improve function.
ACR: Conditionally recommends radiofrequency ablation for knee OA.
Will Medicare cover it?
UNSURE for your plan. Coverage varies by local policy and technique; obtain written confirmation.